Inebilizumab (Biosimilar Reference Antibody) (CD19)
Product Specifications
CAS Number
1299440-37-1
Synonyms
MEDI-551, Medi-551, inebilizumab-cdon
Expression System
CHO
Reaction Volume
Human
Immunogen
CD19
Target
CD19
Clonality
Monoclonal
Conjugation
Non-conjugated
Type
Antibody
Applications
ELISA; FC ; Functional Assays; IF
Endotoxin
<1.0 EU/mg as determined by LAL method
Purity
>98% by SDS-PAGE
Buffer
0.01M PBS, pH 7.4, contains no stabilizers or preservatives.
Storage Conditions
Store at -20°C or -80°C. Avoid repeated freeze.
Host or Source
Humanised
Recommended Usage
For research use only
Isotype
IgG1 - kappa
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS143405-01 0.002 mg
Recombinant Human BH3 Interacting Domain Death Agonist
Sign In for Pricing
View Details MBS143405-02 0.01 mg
Recombinant Human BH3 Interacting Domain Death Agonist
Sign In for Pricing
View Details MBS143405-03 1 mg
Recombinant Human BH3 Interacting Domain Death Agonist
Sign In for Pricing
View Details 
MBS143405-04 5x 1 mg
Recombinant Human BH3 Interacting Domain Death Agonist
Sign In for Pricing
View Details